about
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductaseInhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity.Evaluation of Plasma Isoprostane in Patients with Oral Lichen Planus.RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.Factor Xa Signaling Contributes to the Pathogenesis of Inflammatory Diseases.Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.Does at-home bleaching induce systemic oxidative stress in healthy subjects?Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity.The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma.Comparative measurement of ghrelin, leptin, adiponectin, EGF and IGF-1 in breast milk of mothers with overweight/obese and normal-weight infants.Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways.Evaluation of the effect of diacetyl morphine on salivary factors and their changes after methadone therapy.The association between neutrophilic hypersegmentation and iron deficiency with regard to folate status in 16-30 year-old women.Therapeutic potency of heat-shock protein-70 in the pathogenesis of colorectal cancer, current status and perspectivesOxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatmentThioredoxin Reductase Gene Expression and Activity among HTLV-1 Infected PatientsEvaluation of serum levels of oxidized and reduced glutathione and total antioxidant capacity in patients with head and neck squamous cell carcinomaThe role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathwaysThe immunomodulatory effects of tachykinins and their receptorsEvaluation of the oxidant-antioxidant balance, isoprostane and quantitative CRP in patients with cutaneous leishmaniasisPD-1/ PD-L1 blockade as a novel treatment for colorectal cancerMolecular targeting for treatment of human T-lymphotropic virus type 1 infectionRole of tumor microenvironment in the regulation of PD-L1: A novel role in resistance to cancer immunotherapyClinical Trial Assessment of Intermittent and Continuous Infusion Dose of N-Acetylcysteine on Redox Status of the Body in Patients with Sepsis Admitted to the ICUMicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives5'-Adenosine monophosphate-activated protein kinase: A potential target for disease prevention by curcuminEvaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancerEmerging roles of microRNAs in regulating the mTOR signaling pathway during tumorigenesisEvaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancerNew insight into the Role of Substance P/Neurokinin-1 Receptor System in Breast Cancer Progression and Its Crosstalk with MicroRNAsEvaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancerNovelty in limbal stem cell culture and cell senescenceSerum hepcidin level and rheumatoid arthritis disease activityThe thioredoxin system and cancer therapy: a reviewThe emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cellsLeptin-induced signaling pathways in cancer cell migration and invasionRecent advances in the clinical development of immune checkpoint blockade therapyCytokines as potential combination agents with PD-1/PD-L1 blockade for cancer treatmentHerbal medicine in oral lichen planusThe cross-talk between adipokines and miRNAs in health and obesity-mediated diseases
P50
Q28567883-68999B1C-2EA2-49C8-A0BA-984CE945E5A5Q34758907-992F2728-5FDE-4393-8394-73DA6FD7BA40Q36630507-141E9F0B-5294-44C5-ACBE-270D07FDFC69Q38289359-89C74A28-58F6-44EA-872C-DB0C73165C07Q39031297-5E24D215-CC07-4A71-961A-38C05698EA85Q39165476-1B7BC8AF-FF85-45B3-BA5D-361E284127ABQ39841427-DC2ED57C-23C0-41A2-80CB-11309C42157CQ42170005-89D6D83E-B9B9-46A7-9390-CF215F8997C0Q42498586-16C2739A-7E8B-4A0B-A3AE-780EE932E5C2Q47428386-43C7ACAA-B655-498E-B1AF-32B5F2C00CA0Q48103478-5C9A3B1E-92B1-4570-B1F5-FC55D640B5D3Q52306836-69AD0166-C1DF-40DA-8A1F-84E4773F86ACQ53059465-8997CC26-F677-41E3-A8B1-3A014C6D259FQ57052474-96023025-24B5-401F-B6D4-2408D73D1979Q59348157-CF59B1F4-354C-4F34-B938-B72F06FD8792Q59349593-76370141-1372-45C0-AB4A-61FA8877CC80Q87999860-B0FDA01E-6D26-45D7-ACB4-93C079966203Q89771422-F55BC72E-0791-44E0-84DB-A85B48E3BFB0Q89961268-142B7C19-B8E6-4920-9E82-ECFE777EE5A3Q90077649-64C25899-963E-4065-97A4-6FB9F3182B7CQ90310016-DC7C4311-3A0C-4DD4-9726-8FEE2E4A0DFCQ90513901-37A90C61-DAA6-4681-9C2D-9C054637B14BQ90841503-27D41248-05D4-4731-A3B5-3B8AB69EF684Q91016911-61753ACF-A7B6-405F-8A3D-419B6B386FCDQ91055764-97A8095E-E37D-4CA0-B35B-76E823E65741Q91148072-9B76E6B7-FC0F-44C8-9A71-3281B43D6447Q91230533-350C76AC-9A0E-48D7-8722-8AF91EC102B8Q91344501-10E76B98-7675-42F3-A815-E852993E79FEQ91500125-217269F1-BBAB-414B-A270-01328A2215C8Q91719625-C1E4749B-8E69-4C05-B920-2F6BCAB738FBQ91819159-130C5614-C575-4194-8C2E-ABB0B2D79725Q91935049-CF63AC36-32D1-4CDD-9145-3CE68C5C1F1BQ92310651-7A60DD76-3D23-4D0C-AE12-B4B29E52E1F7Q92327874-532780A7-AAE7-4C83-ABEF-BA1ECDE7C899Q92360253-23391695-5F81-4ACD-BDC8-56AF147122CFQ92405944-91A6372A-F404-4366-BF1A-E333C7E9F685Q92763654-4D57CE96-3887-4EB7-991E-4AF6AD42A773Q92866775-C4E5A13B-98A8-495A-86B8-0E94EE5A9483Q93025080-6F2E3D09-D6EE-4EDF-A50A-C05DAA3A6F99Q93055768-AF1F9095-9966-4131-B980-3F7C88763FFC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Seyed Isaac Hashemy
@en
Seyed Isaac Hashemy
@nl
type
label
Seyed Isaac Hashemy
@en
Seyed Isaac Hashemy
@nl
prefLabel
Seyed Isaac Hashemy
@en
Seyed Isaac Hashemy
@nl
P31
P496
0000-0002-1323-5250